In a piece she writes for Newsweek, Sharon Begley says NIH's Cancer Genome Atlas "may be fatally flawed." And the price tag for TCGA means that "the atlas threatens to suck up ever-dwindling resources." The article explores the concept of the project and quotes scientists who argue that the its potential gain doesn't come close to justifying its expense.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.